The overexpression of amyloid-β precursor protein (APP) in the brain of Alzheimer’s disease (AD) leads to the binding of APP to Fe65 protein, which, in turn, triggers the secretion of amyloid-β, leading to the pathogenesis of AD. This evidence concerns the gene APBB1 and Alzheimer disease.